| | Characteristics | Non-CR (N = 39) | CR (N = 52) | value |
| | Age, years# | 59.46 ± 11.01 | 69.79 ± 11.67 | <0.001 | | Height (m)# | 1.70 ± 0.08 | 1.66 ± 0.09 | 0.062 | | Weight (Kg)# | 68.56 ± 9.64 | 67.79 ± 11.60 | 0.736 | | BMI (Kg/m2)# | 23.71 ± 2.43 | 24.41 ± 2.89 | 0.225 | | Oxygen saturation (%) | 91.0 (89.0, 93.0) | 90.0 (90.0, 92.8) | 0.827 | | SBP (mmHg)# | 126.3 ± 27.2 | 127.4 ± 22.3 | 0.837 | | DBP (mmHg)# | 74.9 ± 14.9 | 73.2 ± 12.5 | 0.553 | | Heart rate# | 76.5 ± 14.8 | 77.1 ± 16.2 | 0.854 | | White blood cell | 7.32 (5.55, 10.06) | 7.17 (5.71, 11.33) | 0.721 | | Red blood cell | 4.89 (4.40, 5.54) | 4.70 (4.25, 5.22) | 0.342 | | Hemoglobin# | 153.2 ± 28.7 | 149.5 ± 20.3 | 0.500 | | Glycosylated hemoglobin | 5.63 (5.38, 6.19) | 6.06 (5.52, 7.17) | 0.005 | | PT | 12.0 (11.7, 12.7) | 11.9 (11.4, 12.5) | 0.271 | | APTT | 28.7 (26.7, 32.3) | 26.9 (24.3, 31.0) | 0.008 | | ALT | 37.0 (19.0, 82.0) | 28.5 (19.3, 42.0) | 0.183 | | AST | 48.0 (22.0, 221.0) | 33.5 (21.3, 109.5) | 0.195 | | AST/ALT | 1.3 (0.9, 3.4) | 1.2 (0.8, 2.3) | 0.431 | | Urea nitrogen | 5.91 (4.97, 10.04) | 6.28 (5.25, 7.99) | 0.745 | | Creatinine | 83.0 (67.0, 96.0) | 84.0 (67.3, 92.8) | 0.591 | | Glomerular filtration rate (mL/min × 1.73 m2)# | 80.7 ± 28.3 | 76.0 ± 22.7 | 0.389 | | Albumin | 38.2 (34.7, 41.1) | 37.8 (34.9, 39.7) | 0.510 | | Total cholesterol (mmol/L)# | 4.00 ± 1.22 | 4.17 ± 1.05 | 0.478 | | Triglyceride | 1.32 (0.90, 1.97) | 1.59 (0.90, 2.38) | 0.432 | | TSH | 1.19 (0.54, 2.68) | 1.68 (1.20, 2.89) | 0.156 |
| | Sex, n (%) | | | 0.022 | | Male | 32 (82.1) | 31 (59.6) | | | Female | 7 (17.9) | 21 (40.4) | |
| | Aspirin resistance, n (%) | | | <0.001 | | No | 28 (71.8) | 14 (26.9) | | | Yes | 11 (28.2) | 38 (73.1) | |
| | Smoking history, n (%) | | | 0.328 | | No | 20 (51.3) | 32 (61.5) | | | Yes | 19 (48.7) | 20 (38.5) | |
| | Coronary heart disease type, n (%) | | | 0.041 | | STEMI | 19 (48.7) | 23 (44.2) | | | NSTEMI | 8 (20.5) | 4 (7.7) | | | SAP | 2 (5.1) | 13 (25.0) | | | UA | 10 (25.6) | 12 (23.1) | |
| | Hypertension, n (%) | | | 0.157 | | No | 16 (41.0) | 14 (26.9) | | | Yes | 23 (59.0) | 38 (73.1) | |
| | Diabetes, n (%) | | | 0.004 | | No | 26 (66.7) | 19 (36.5) | | | Yes | 13 (33.3) | 33 (63.5) | |
| | Stroke, n (%) | | | 0.899 | | No | 25 (64.1) | 34 (65.4) | | | Yes | 14 (35.9) | 18 (34.6) | |
| | Hyperlipidaemia, n (%) | | | 0.355 | | No | 21 (53.8) | 33 (63.5) | | | Yes | 18 (46.2) | 19 (36.5) | |
| | CYP2C192, n (%) | | | 0.412 | | GG | 24 (61.5) | 37 (71.2) | | | GA | 11 (28.2) | 13 (25.0) | | | AA | 4 (10.3) | 2 (3.8) | |
| | CYP2C192, n (%) | | | 0.334 | | GG | 24 (61.5) | 37 (71.2) | | | GA + AA | 15 (38.5) | 15 (28.8) | |
| | CYP2C193, n (%) | | | 0.387 | | GG | 22 (56.4) | 22 (42.3) | | | GA | 10 (25.6) | 16 (30.8) | | | AA | 7 (17.9) | 14 (26.9) | |
| | CYP2C193, n (%) | | | 0.183 | | GG | 22 (56.4) | 22 (42.3) | | | GA + AA | 17 (43.6) | 30 (57.7) | |
| | CYP2C1917, n (%) | | | 0.532 | | GG | 23 (59.0) | 34 (65.4) | | | GA | 16 (41.0) | 18 (34.6) | |
|
|
